Top Regional Bank Stocks To Buy Right Now

Top Regional Bank Stocks To Buy Right Now: Sinovac Biotech Ltd.(SVA)

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against the hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. It offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination of hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the influenza A H1N1 virus. The company's pipeline vaccine candidates include a split viron vaccine, which completed Phase II clinical trials for the H5N1 influenza virus; and a SARS vaccine, which completed Phase I clinical trials for the SARS virus. In addition, its pipeline vaccine candidates that completed the pre-clinical trials comprise human vaccines for EV71, pneumococcal conjugate, haemophilus influenzae type b, meningitis, Japanese encephalitis, chickenpox, mumps, and rubella diseases, as well as rabies vaccine for humans and animals. The company markets and sell s its vaccine products directly to the provincial and municipal disease control and prevention centers. It has a patent license agreement with the National Institutes of Health; distribution agreements with LG Life Sciences, Ltd. and Glovax C.V.; and a pandemic influenza vaccine co-development agreement with the China Center for Disease Control and Prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.

Advisors' Opinion:

• [By Rich Duprey]

  Troubling is that it's a new presence in humans, and while that makes its spread among the populace difficult, scientists fear that it's gaining momentum. Sinovac Biotech (NASDAQ: SVA  ) , which was approved to produce vaccines several years ago, jumped almost 7% yesterday as it gears up to mass produce a vaccine to combat the new threat.

• [By Louis Navellier]

  LGND is a strong buy at today! s price.

  Biotech Stocks to Buy: Sinovac Biotech (SVA)

  Sinovac Biotech LTD (SVA) is a Chinese biotech company that makes drugs to treat conditions such as hepatitis A, hepatitis B, and influenza viruses. The just announced that the phase three trials of a new drug to fight a virus called EV-71 that causes neurological conditions such hand foot and mouth disease showed great promise. Phase III trial results EV71 vaccine show that the drug had a 94.8% efficacy rate against EV71-related hand, foot, and mouth disease, and a 100% efficacy rate against EV71-associated hospitalization and against HFMD with neurologic complications.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-regional-bank-stocks-to-buy-right-now-2.html